Atlas Trials

Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer

Clinical trial NCT00440973 · TERMINATED

Trial details

NCT number
NCT00440973
Sponsor
The Methodist Hospital Research Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Renal Cell
Start date
2006-10-01
Primary completion
2007-10-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.